ATLANTA, Georgia, April 8, 2026 — Andson Biotech will attend and present at IBBI — Isolated Biomolecules and Biomolecular Interactions, an international scientific meeting bringing together researchers studying biomolecular structure, dynamics, and interactions across disciplines.
Following the successful debut of the DynaChip X1™ platform in 2025, Andson Biotech will highlight its cutting‑edge, chip‑based technology designed to transform mass spectrometry and biomolecular analysis workflows. At IBBI, Andson will present posters demonstrating how the DynaChip X1™ enables rapid, efficient, and reproducible sample preparation for complex biomolecular systems.
- Rapid Online Buffer Exchange for Native Analysis of Complex Biomolecular Systems
- DynaChip Online Buffer Exchange and Desalting Coupled to CD-MS for the Analysis of Large Biologics
The DynaChip X1™ platform is a breakthrough microfluidic technology enabling rapid online buffer exchange while minimizing manual handling. By improving analytical consistency and reducing sample preparation time, the platform is designed to empower scientists to push the boundaries of fundamental research and biotherapeutic development.
Throughout the meeting, the Andson team will engage with attendees from academia and industry to discuss new applications, technical innovations, and emerging challenges in biomolecular and native mass spectrometry workflows. Participation in IBBI reflects Andson Biotech’s continued commitment to advancing tools that simplify experimentation and accelerate scientific discovery.
Andson Biotech looks forward to contributing to the collaborative discussions at IBBI and to connecting with researchers driving the next generation of biomolecular analysis.
